Arda Therapeutics
Austin, US · 2 known investors
Arda develops therapeutics using single-cell computational biology to target and eliminate pathogenic cells in chronic diseases. The company combines drug development expertise with cellular biology to create new therapeutic approaches.
AI & Machine LearningBiotechMedical Devices
Founders & leadership
AF
Adam FreundFounder & Chief Executive Officer
RL
Remi-Martin LabergeFounder and Chief Technology Officer
Investors · 2
In the news
- Sell or Invest in Arda Therapeutics Stock Pre-IPOnasdaqprivatemarket.com · 2025
- Arda Therapeutics Raises $43M in Series A Financingfinsmes.com · 2024
- Arda Therapeutics Secures $43M Series A Financing to Advance Targeted Cell Depletion Therapies — Arda Therapeuticsardatx.com · 2024
- Exclusive: Lilly backs a16z-funded Arda Therapeutics’ $43M Series A to take ADCs into fibrosisendpoints.news · 2024
- Arda Therapeutics - $43M Early Stage Venture | Startup Introsstartupintros.com · 2024
- Arda Therapeutics - 2026 Company Profile, Team, Funding & Competitors - Tracxntracxn.com · 2022